Preeclampsia Drugs Market Competitve Landscape 2024-2033 – Major Players and Strategies

Overview and Scope
Preeclampsia drugs refer to medications that manage and treat the condition of pre-eclampsia, a serious pregnancy complication characterized by high blood pressure and damage to organs like the liver and kidneys. These drugs are typically prescribed by healthcare professionals to pregnant women diagnosed with preeclampsia to help lower blood pressure and prevent further complications.

Sizing and Forecast
The preeclampsia drugs market size has grown rapidly in recent years. It will grow from $1.13 billion in 2023 to $1.25 billion in 2024 at a compound annual growth rate (CAGR) of 10.7%.  The  growth in the historic period can be attributed to increased maternal health awareness, research and development, neonatal health concerns, early detection.

The preeclampsia drugs market size is expected to see rapid growth in the next few years. It will grow to $1.89 billion in 2028 at a compound annual growth rate (CAGR) of 10.9%.  The growth in the forecast period can be attributed to personalized medicine, non-invasive diagnostic tools, targeted therapies, health equity initiatives. Major trends in the forecast period include preventive strategies, patient-centered care, continuous monitoring, regulatory focus.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/preeclampsia-drugs-global-market-report

Segmentation & Regional Insights
The preeclampsia drugs market covered in this report is segmented –
1) By Type: Mild Preeclampsia; Severe Preeclampsia
2) By Treatment: Medication to Lower Hypertension (B.P); Corticosteroids; Anticonvulsants Medication
3) By Route of Administration: Oral; Parenteral; Other Route of Administration
4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacies; Other Distribution Channels
5) By End-User: Hospitals; Specialty Clinics; Diagnostic Centers; Other End-Users

North America was the largest region in the preeclampsia drugs market in 2023. The regions covered in preeclampsia drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13025&type=smp

Major Driver Impacting Market Growth
The rise in diabetes cases among pregnant women is expected to propel the growth of the preeclampsia drug market going forward. Diabetes is a metabolic disease that is chronic and characterized by high blood glucose (or blood sugar) levels. Preeclampsia is a harmful pregnancy condition with elevated blood pressure and organ damage. Metformin, a preeclampsia medicine, is widely used in pregnant women with preterm preeclampsia. For instance, in December 2022, according to the National Library of Medicine, a US-based biomedical library and center of biomedical informatics, the total incidence of gestational diabetes mellitus (GDM) was 20,865 cases, an increase of 6.56% in 2022. Therefore, the rise in diabetes cases among pregnant women will drive the preeclampsia drug market.

Key Industry Players
Major players in the preeclampsia drugs market are  AbbVie Inc., Pfizer Inc., Johnson & Johnson Co, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Sanofi S.A., Celgene Corp, Thermo Fisher Scientific Inc., AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Takeda Pharmaceuticals Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Siemens Healthcare GmbH, Boehringer Ingelheim Group, Viatris Inc., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Union Chimique Belge SA, Otsuka Pharmaceutical Co. Ltd., Kyowa Kirin Co Ltd., Mallinckrodt Pharmaceuticals Limited, Comanche Biopharma Corp, Genentech Inc., Diabetomics Inc.

The preeclampsia drugs market report table of contents includes:
1. Executive Summary

2. Preeclampsia Drugs Market Characteristics
3. Preeclampsia Drugs Market Trends And Strategies
4. Preeclampsia Drugs Market – Macro Economic Scenario
5. Global Preeclampsia Drugs Market Size and Growth
   .
6. Global Preeclampsia Drugs Market Competitive Benchmarking
7. Global Preeclampsia Drugs Market Competitive Dashboard
8. Key Mergers And Acquisitions In The Preeclampsia Drugs Market
9. Preeclampsia Drugs Market Future Outlook and Potential Analysis
10. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model